High materiality7/10
Haemonetics price target raised to $105 from $90 at Raymond James
Why it may matterVerify against the original reporting
Upside implied by higher target relative to current price.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Raymond James raises HAE target to $105 from $90; current price $85.73.
- Target raised to $105; price $85.73.
Key facts
- 01
Target: $105
- 02
Posted price: $85.73
- 03
Analyst firm: Raymond James
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.